Inventor · disambiguated record
Songyuan Shi
Also filed as: SHI SONGYUAN
35 granted patents·12 pending applications·595 citations·filing 2000–2024
98Inventor score
Top patents by PatentIndex Score
47 records- 0199US9469640B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Oct 18, 2016·44 cites·12 claims
- 0298US8198273B2Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA N·Filed 2010·Granted Jun 12, 2012·65 cites·11 claims
- 0397US9844539B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Dec 19, 2017·20 cites·30 claims
- 0497US8673928B2Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA N·Filed 2010·Granted Mar 18, 2014·60 cites·15 claims
- 0596US9771363B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2016·Granted Sep 26, 2017·34 cites·20 claims
- 0696US9617267B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2014·Granted Apr 11, 2017·38 cites·6 claims
- 0796US8153641B2Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA N·Filed 2009·Granted Apr 10, 2012·51 cites·8 claims
- 0895US10899761B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2020·Granted Jan 26, 2021·4 cites·6 claims
- 0995US10370374B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2018·Granted Aug 6, 2019·17 cites·22 claims
- 1095US9975894B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2017·Granted May 22, 2018·20 cites·21 claims
- 1195US9814714B2Kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Nov 14, 2017·22 cites·31 claims
- 1295US9718847B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2014·Granted Aug 1, 2017·33 cites·21 claims
- 1395US9624213B2Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA·Filed 2012·Granted Apr 18, 2017·38 cites·4 claims
- 1494US9856259B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2015·Granted Jan 2, 2018·20 cites·20 claims
- 1593US8268858B2Compounds and methods for kinase modulation, and indications thereforWU GUOXIAN·Filed 2007·Granted Sep 18, 2012·49 cites·11 claims
- 1692US10426760B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2018·Granted Oct 1, 2019·6 cites·52 claims
- 1792US9873700B2Compounds for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2014·Granted Jan 23, 2018·20 cites·8 claims
- 1892US7262182B2Sulfonylethyl phosphorodiamidatesTELIK INC·Filed 2005·Granted Aug 28, 2007·12 cites·14 claims
- 1991US10647716B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2019·Granted May 12, 2020·7 cites·6 claims
- 2088US10703757B2Compounds and methods for CDK8 modulation and indications thereforPLEXXIKON INC·Filed 2017·Granted Jul 7, 2020·4 cites·38 claims
- 2188US10421761B2Compounds for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2017·Granted Sep 24, 2019·6 cites·11 claims
- 2287US10160747B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2017·Granted Dec 25, 2018·8 cites·25 claims
- 2385US2025195516A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2024·Application pending·0 cites
- 2484US10519177B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2017·Granted Dec 31, 2019·4 cites·22 claims
- 2584US10227357B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2013·Granted Mar 12, 2019·7 cites·7 claims
- 2683US12076322B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2022·Granted Sep 3, 2024·0 cites·7 claims
- 2783US11807626B2Compounds and methods for CD73 modulation and indications thereforOpna Bio SA·Filed 2021·Granted Nov 7, 2023·1 cites·40 claims
- 2880US2021353602A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2021·Application pending·0 cites
- 2980US2021346358A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2021·Application pending·0 cites
- 3079US12116365B2Heterocyclic compounds and uses thereofOpna Bio SA·Filed 2022·Granted Oct 15, 2024·0 cites·16 claims
- 3177US11337976B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2017·Granted May 24, 2022·1 cites·10 claims
- 3273US12202818B2Compounds and methods for CD73 modulation and indications thereforOpna Bio SA·Filed 2023·Granted Jan 21, 2025·0 cites·31 claims
- 3372US11446287B2Compounds and methods for EP300 or CBP modulation and indications thereforOPNA IMMUNO ONCOLOGY SA·Filed 2020·Granted Sep 20, 2022·1 cites·37 claims
- 3470US2019209536A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2018·Application pending·0 cites
- 3569US2010190777A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2008·Application pending·0 cites
- 3668US2014303187A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2014·Application pending·0 cites
- 3767US2017319559A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2017·Application pending·0 cites
- 3866US2013237531A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2013·Application pending·0 cites
- 3965US7071231B2Naphthalene ureas as glucose uptake enhancersTELIK INC·Filed 2002·Granted Jul 4, 2006·2 cites·20 claims
- 4064US2025129028A1Compounds and methods for yap/tead modulation and indications thereforOpna Bio SA·Filed 2024·Application pending·0 cites
- 4163US2014038948A1Compounds and methods for kinase modulation, and indications thereforWU GUOXIAN·Filed 2013·Application pending·0 cites
- 4262US6458998B1Naphthalene ureas as glucose uptake enhancersTELIK INC·Filed 2000·Granted Oct 1, 2002·1 cites·37 claims
- 4356US8093231B2Sulfonylethyl phosphorodiamidatesALLEN DAVID R·Filed 2007·Granted Jan 10, 2012·0 cites·4 claims
- 4455US2023081426A1Compounds and methods for kras modulation and indications thereforPLEXXIKON INC·Filed 2021·Application pending·0 cites
- 4550US12509444B2Compounds and methods for CD73 modulation and indications thereforPLEXXIKON INC·Filed 2020·Granted Dec 30, 2025·0 cites·14 claims
- 4649US2012245174A1Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA N·Filed 2012·Application pending·0 cites
- 4736US6653321B1Naphthylsulfonic acids and related compounds as glucose uptake agonistsTELIK INC·Filed 2000·Granted Nov 25, 2003·0 cites·30 claims
Join the waitlist — get patent alerts
Get an alert when Songyuan Shi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →